Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Reports from University of California add new data to research in cancer vaccines
April 16th, 2008
According to recent research from the United States, "Despite recent advances in therapy for lung cancer, median survival remains poor. Cancer vaccines might meet the unmet need for new and effective therapies with low toxicity." "A better understanding of the Immunology of cancer has led to novel strategies for vaccine delivery, including the use of immunogenic adjuvant agents, genetic modification of tumor cells to produce cytokines, viral vectors, and the use of antigen-presenting cells. A number of these strategies have been studied in clinical trials for lung cancer," wrote J. Kim and colleagues, University of California. The researchers...
Source: Vaccine Weekly (2008-04-16)
|
